Teva’s (TEVA) Q3 Earnings and Revenues Miss, Stock Down

Posted byZacks Equity Research Leave a comment on Teva’s (TEVA) Q3 Earnings and Revenues Miss, Stock Down

Teva Pharmaceutical Industries’ (TEVA) shares decline after the company misses both earnings and sales estimates for third-quarter 2021. Meanwhile, it reaffirms its 2021 guidance.

Leave a comment

Your email address will not be published. Required fields are marked *